Skip to Primary Navigation

Skip to main content

Anthropic debuts AI-driven life sciences ‘workbench’

A photo of two people speaking on a stage beneath a blue background image of mountains with the words Anthropic and Snowflake across it.
Photo: Minh Connors/Getty Images

Kevin Kinsella

2 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

As Anthropic pushes deeper into life sciences, the FDA is sharpening rules around AI‑enabled research and the use of computational predictions in regulated development pipelines.

Anthropic has rolled out Claude Science, an AI‑driven research “workbench” now in beta, aimed at scientists working across genomics, proteomics, structural biology, and related fields.

The release marks the company’s latest effort to position its Claude models as tools for technical, computation‑heavy research rather than general‑purpose chat assistants.

, , , , , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience